Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.74    0.13 (8.07%)
Bid:
1.61
Ask:
1.75
Spread: 0.14 (8.696%)
Market Cap: £34.91m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Director / PDMR Shareholding

25 Jul 2025 07:00

RNS Number : 5149S
Quadrise PLC
25 July 2025
 

25 July 2025

 

Quadrise plc

("Quadrise", "QED" or the "Company")

 

Director / PDMR Shareholding

 

 

Quadrise plc (AIM: QED), the technology company focused on the decarbonisation of shipping and heavy industry through deployment of low emission fuels and biofuels, announces that it has been notified, in accordance with the intentions set out in the Company's announcement of 4 July 2025, that Jason Miles, Chief Technology Officer of the Company, and Philip Hill, Chief Commercial Officer, sold an aggregate of 1,276,492 ordinary shares in the capital of the Company ("Ordinary Shares") between them at a weighted average price of 3.60 pence per Ordinary Share on 24 July 2025.

 

Following the exercise of share options announced on 4 July 2025 and the subsequent sale of shares to cover costs and taxes, the resultant shareholding of Jason Miles has increased to 10,820,876 ordinary shares and that of Philip Hill has increased to 2,852,533 ordinary shares.

 

The notifications below, made in accordance with the UK Market Abuse Regulation, provide further details.

 

For further information please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Technology Officer

 

 

Nominated Adviser

Cavendish Capital Markets Limited

 

 

+44 (0)20 7220 0500

Ben Jeynes

Katy Birkin

George Lawson

 

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Harry Davies-Ball (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

 

 

+44 (0)20 3005 5000

 

Public & Investor Relations

 

 

Tavistock Communications (Financial PR & IR)

Simon Hudson

Nick Elwes

Ruairi Millar

 

+44 (0) 20 7920 3150

 

 BLUE Communications Limited (Marine & Trade PR)

 Rhys Thomas

 Sam Deacon

 

 

 

+44 (0)7595 227750

+44 (0)7527 558846

 

 

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to lower energy costs, pollution and greenhouse gas emissions today for the global power generation, shipping, industrial and oil industries.

Learn more at: www.quadrise.com

 

Follow us on social media:

LinkedIn: @Quadrise Plc

X: @QuadrisePlc

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jason Miles

 

2

Reason for notification

a)

Position/Status

PDMR (Chief Technology Officer)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Quadrise plc

 

b)

LEI

213800HN2ETG5476U328

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 1 pence each

 

ISIN: GB00B11DDB67

 

b)

Nature of transaction

1Disposal of ordinary shares

 

c)

Price(s) and volume(s)

Prices

Volume(s)

 

3.60p

1,013,049

 

 

 

d)

Aggregated information

 n/a

 

 

e)

Date of transaction

24 July 2025

 

 

f)

Place of transaction

AIMX

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Philip Hill

 

2

Reason for notification

a)

Position/Status

Chief Commercial Officer

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Quadrise plc

 

b)

LEI

213800HN2ETG5476U328

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 1 pence each

 

ISIN: GB00B11DDB67

 

b)

Nature of transaction

Sale of ordinary shares

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

3.60p

263,443

 

 

d)

Aggregated information

 n/a

 

 

e)

Date of transaction

 24 July 2025

 

 

f)

Place of transaction

AIMX

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSVWRVWUBUAR
Date   Source Headline
6th Nov 20139:00 amRNSChange in Director's details
6th Nov 20137:30 amRNSNotice of General Meeting
4th Nov 201311:16 amRNSProposed Disposal of Interests in GPRL JV
1st Nov 20135:10 pmRNSDirector/PDMR Shareholding
1st Nov 20135:10 pmRNSTotal Voting Rights
31st Oct 20134:00 pmRNSHolding(s) in Company
9th Oct 20134:30 pmRNSHolding(s) in Company
9th Oct 201310:00 amRNSDirector/PDMR Shareholding
2nd Oct 20134:31 pmRNSTotal Voting Rights
2nd Oct 20134:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20133:02 pmRNSDisposal of SeQuel
16th Sep 20135:19 pmRNSDirector/PDMR Shareholding
10th Sep 20137:00 amRNSAdditional Listing
3rd Sep 20135:23 pmRNSTotal Voting Rights
3rd Sep 20135:19 pmRNSDirector/PDMR Shareholding
2nd Sep 20137:30 amRNSUpdate of Sequel
21st Aug 20134:30 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
15th Aug 20135:18 pmRNSHolding(s) in Company
14th Aug 20134:30 pmRNSHolding(s) in Company
7th Aug 20134:01 pmRNSTotal Voting Rights
7th Aug 20134:00 pmRNSDirector/PDMR Shareholding
7th Aug 20137:00 amRNSFirst Quarter Interim Management Statement
5th Aug 20134:00 pmRNSHolding(s) in Company
22nd Jul 20135:40 pmRNSDirector/PDMR Shareholding
22nd Jul 20135:35 pmRNSDirector/PDMR Shareholding
22nd Jul 20135:26 pmRNSDirector/PDMR Shareholding
22nd Jul 20135:25 pmRNSDirector/PDMR Shareholding
22nd Jul 20134:30 pmRNSResult of AGM
19th Jul 20132:42 pmRNSQuintain Launches Seven Year 6.5% Sterling Bond
12th Jul 20137:00 amRNSGreenwich Peninsula JV wins planning approval
2nd Jul 201312:01 pmRNSTotal Voting Rights
2nd Jul 201312:00 pmRNSDirector/PDMR Shareholding
26th Jun 20135:09 pmRNSHolding(s) in Company
17th Jun 201312:00 pmRNSAnnual Financial Report
4th Jun 20134:01 pmRNSTotal Voting Rights
4th Jun 20134:00 pmRNSDirector/PDMR Shareholding
23rd May 20137:02 amRNSAppointment of Non-Executive Director
23rd May 20137:00 amRNSResults for the year ended 31 March 2013
22nd May 20135:19 pmRNSHolding(s) in Company
3rd May 20132:32 pmRNSNotice of Results
30th Apr 20134:01 pmRNSTotal Voting Rights
30th Apr 20134:00 pmRNSDirector/PDMR Shareholding
11th Apr 20137:00 amRNSHolding(s) in Company
2nd Apr 20137:00 amRNSAnnounces Hilton London Wembley joint venture
2nd Apr 20137:00 amRNSDirector/PDMR Shareholding
2nd Apr 20137:00 amRNSTotal Voting Rights
12th Mar 20131:31 pmRNSGreenwich Peninsula Investor/Analyst Presentation
11th Mar 20139:31 amRNSWembley Investor and Analyst Presentation
4th Mar 20133:13 pmRNSTotal Voting Rights
4th Mar 20133:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.